WVC 2021
Mandalay Bay Convention Center 393 Frank Sinatra Dr, Las Vegas, NVSymposia September 9, 2021 @ 8:00 AM Title: S37A - Cancer as a Disease of the Genome – Explained Speaker: Daniel S. Grosu, MD, MBA, PetDx President & CEO Synopsis: Basic overview of landmark discoveries in genomics over the past decade, with a focus on cancer biology principles and relevance in dogs. The session will […]
2021, Sep 30 – Free CE Webinar
GoToWebinarTitle: Liquid biopsy for non-invasive multi-cancer detection and characterization in dogs. Synopsis: Blood-based liquid biopsy for veterinary applications will be introduced, including a review of the current clinical approach to cancer diagnosis, and opportunities for cell-free DNA-based liquid biopsy testing in dogs. Multiple clinical use cases for liquid biopsy in cancer detection will be described, including screening for early detection; aid in diagnosis; and monitoring for residual or recurrent disease. This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval (Tracking number 20-848616).
WSVMA PNWVC 2021
VirtualThe premier conference for Pacific Northwest veterinarians, technicians, practice managers, practice staff, and veterinary students.
2021, Oct 7 – Webinar with VIN
VirtualVeterinary Information Network – Webinar
Detecting Cancer in Dogs with Just a Blood Draw: An Introduction to Liquid Biopsy
2021, Oct 22 – Free CE Webinar
GoToWebinarTitle: Liquid biopsy for non-invasive multi-cancer detection and characterization in dogs. Synopsis: Blood-based liquid biopsy for veterinary applications will be introduced, including a review of the current clinical approach to cancer diagnosis, and opportunities for cell-free DNA-based liquid biopsy testing in dogs. Multiple clinical use cases for liquid biopsy in cancer detection will be described, including screening for early detection; aid in diagnosis; and monitoring for residual or recurrent disease. This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval (Tracking number 20-848616).